The impact of National Centralized Drug Procurement policy on the use of policy-related original and generic drugs in public medical institutions in China: A difference-in-difference analysis based on national database
Jing Wang, View ORCID ProfileYing Yang, Luxinyi Xu, Yuan Shen, Xiaotong Wen, Lining Mao, Quan Wang, Dan Cui, Zongfu Mao
doi: https://doi.org/10.1101/2021.06.21.21256568
Jing Wang
1Department of Drug Information Management, Statistical Information Center, National Health Commission of the People’s Republic of China, Beijing 100044, China
Ying Yang
2School of Health Sciences, Wuhan University, No. 115 Donghu Road, Wuhan 430071, China
3Global Health Institute, Wuhan University, No. 8 Donghu South Road, Wuhan 430072, China
Luxinyi Xu
2School of Health Sciences, Wuhan University, No. 115 Donghu Road, Wuhan 430071, China
3Global Health Institute, Wuhan University, No. 8 Donghu South Road, Wuhan 430072, China
Yuan Shen
1Department of Drug Information Management, Statistical Information Center, National Health Commission of the People’s Republic of China, Beijing 100044, China
Xiaotong Wen
2School of Health Sciences, Wuhan University, No. 115 Donghu Road, Wuhan 430071, China
3Global Health Institute, Wuhan University, No. 8 Donghu South Road, Wuhan 430072, China
Lining Mao
2School of Health Sciences, Wuhan University, No. 115 Donghu Road, Wuhan 430071, China
3Global Health Institute, Wuhan University, No. 8 Donghu South Road, Wuhan 430072, China
Quan Wang
2School of Health Sciences, Wuhan University, No. 115 Donghu Road, Wuhan 430071, China
3Global Health Institute, Wuhan University, No. 8 Donghu South Road, Wuhan 430072, China
Dan Cui
2School of Health Sciences, Wuhan University, No. 115 Donghu Road, Wuhan 430071, China
3Global Health Institute, Wuhan University, No. 8 Donghu South Road, Wuhan 430072, China
Zongfu Mao
2School of Health Sciences, Wuhan University, No. 115 Donghu Road, Wuhan 430071, China
3Global Health Institute, Wuhan University, No. 8 Donghu South Road, Wuhan 430072, China
Data Availability
The data used in this study is not publicly available. The dataset (CDSIP database) used and analyzed during the current study is available from the corresponding author on reasonable request. In this study, no additional data is used.
Posted June 28, 2021.
The impact of National Centralized Drug Procurement policy on the use of policy-related original and generic drugs in public medical institutions in China: A difference-in-difference analysis based on national database
Jing Wang, Ying Yang, Luxinyi Xu, Yuan Shen, Xiaotong Wen, Lining Mao, Quan Wang, Dan Cui, Zongfu Mao
medRxiv 2021.06.21.21256568; doi: https://doi.org/10.1101/2021.06.21.21256568
The impact of National Centralized Drug Procurement policy on the use of policy-related original and generic drugs in public medical institutions in China: A difference-in-difference analysis based on national database
Jing Wang, Ying Yang, Luxinyi Xu, Yuan Shen, Xiaotong Wen, Lining Mao, Quan Wang, Dan Cui, Zongfu Mao
medRxiv 2021.06.21.21256568; doi: https://doi.org/10.1101/2021.06.21.21256568
Subject Area
Subject Areas
- Addiction Medicine (403)
- Allergy and Immunology (712)
- Anesthesia (207)
- Cardiovascular Medicine (2970)
- Dermatology (253)
- Emergency Medicine (446)
- Epidemiology (12817)
- Forensic Medicine (12)
- Gastroenterology (830)
- Genetic and Genomic Medicine (4622)
- Geriatric Medicine (423)
- Health Economics (732)
- Health Informatics (2943)
- Health Policy (1073)
- Hematology (393)
- HIV/AIDS (933)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (476)
- Neurology (4412)
- Nursing (238)
- Nutrition (652)
- Oncology (2296)
- Ophthalmology (652)
- Orthopedics (260)
- Otolaryngology (327)
- Pain Medicine (282)
- Palliative Medicine (84)
- Pathology (503)
- Pediatrics (1200)
- Primary Care Research (503)
- Public and Global Health (7008)
- Radiology and Imaging (1545)
- Respiratory Medicine (921)
- Rheumatology (444)
- Sports Medicine (386)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (185)